Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy.

Nanoscale Res Lett · 2011 · PMC3102336 · PMID 27502629

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

It can be observed from Figure 4a that there is an increasing trend in the Caco-2 cellular uptake which shows the 5% DMAB-modified PLGA-TPGS nanoparticles (CNP) >5% DMAB-modified PLGA nanoparticles (ANP) >unmodified PLGA-TPGS nanoparticles (BNP).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.